Severe Aplastic Anemia during Osimertinib Therapy in a Patient with EGFR Tyrosine Kinase Inhibitor–Resistant Non–Small Cell Lung Cancer

Hiroaki Ogata, Yuzo Yamamoto, Taishi Harada, Yoichi Nakanishi, Isamu Okamoto, Eiji Iwama, Eiji Iwama, Koji Kato, Yoshinao Oda

Research output: Contribution to journal › Letter › peer-review

5 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Severe Aplastic Anemia during Osimertinib Therapy in a Patient with EGFR Tyrosine Kinase Inhibitor–Resistant Non–Small Cell Lung Cancer'. Together they form a unique fingerprint.